Seattle startup claims India-based drugmaker stole COVID-19 vaccine tech, seeks $950M
Seattle vaccine company HDT Bio is seeking nearly $1 billion in a new lawsuit alleging that an India-based drugmaker stole HDT’s mRNA COVID-19 vaccine technology. The complaint, filed Monday in...
Read moreDetails









